
|Articles|September 1, 2016
- Pharmaceutical Executive-09-01-2016
- Volume 36
- Issue 9
Pharmaceutical Executive, September 2016 Issue (PDF)
Click the title above to open the Pharmaceutical Executive September 2016 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 10 years ago
Pharm Exec's Emerging Pharma Leaders 2016almost 10 years ago
Emerging Leaders 2016: Lessons from the Front Benchalmost 10 years ago
Patient-Centered Strategies for Clinical Trials & Treatmentalmost 10 years ago
Rise of the Vox Populialmost 10 years ago
Opioid Epidemic Prompts More Finger Pointing at Pharmaabout 10 years ago
Country Report: France, Part IIAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
Novartis, Bristol Myers Pause Autoimmune CAR-T Trials Over Safety Concerns: Report
2
Ultragenyx Shares Drop Following Failed Phase III Clinical Trial
3
FDA Approves Zanvastro for Alexander Disease in Pediatrics & Adults
4
Your Questions Answered: The Biggest Pharma and Biotech Stories This Week
5




